Latest Sprint Bioscience News & Updates
See the latest news and media coverage for Sprint Bioscience. We track all announcements, press releases, and industry mentions in real time, all in one place.
Pharmaceutical company developing oncology drug candidates
sprintbioscience.com- Headquarters
- Huddinge, Sweden
- Founded year
- 2009
- Company type
- Public company
- Number of employees
- 40–50
Latest news about Sprint Bioscience
Company announcements
-
Sprint Bioscience publishes the annual report for 2025
The annual report for the 2025 fiscal year is available on the company's website. Link to the report is in the message.
-
Sprint Bioscience calls an annual general meeting
The annual general meeting is held on 13 May 2026 in Huddinge. The nomination committee proposes board election and remuneration. The board proposes no dividend and authorization to issue shares.
-
Sprint Bioscience expands NNMT program to CKD
The expansion follows proof-of-concept study results showing strong antifibrotic effects in animal models. CEO discusses the opportunity in BioStock Q&A.
-
Sprint Bioscience appoints Jenni Björnulfson as CFO
She will take up the position on May 4 and will contribute experience from life science and finance. CEO Johan Emilsson welcomes her expertise for growth.
Media coverage
-
Sprint Bioscience AB: Sprint Bioscience completes strategic STK25 evaluation; continued focus on the primary indication
Sprint Bioscience AB (publ) today announces the conclusion of a targeted evaluation of the STK25 program, conducted in partnership with the Experimental Drug Development Centre...
-
Sprint Bioscience: Positive results in brain cancer study
Sprint Bioscience announces what the research company describes as positive results from a preclinical proof-of-concept study regarding...
-
Gilead acquires Sprint's pre-clinical TREX1 cancer programme
Gilead Sciences has struck a deal with Sprint Bioscience to license a pre-clinical oncology programme targeting TREX1. Under the agreement, Gilead will pay an initial...
-
Gilead snaps up Sprint’s TREX1 immunotherapy programme for $400m
Gilead Sciences has secured the rights to Sprint Bioscience’s preclinical oncology programme for up ...
Track Sprint Bioscience and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Sprint Bioscience competitors & trending companies
Browse news for competitors to Sprint Bioscience and other trending companies.
Kura Oncology
Medivir
Allarity Therapeutics
Oncopeptides
Vivesto
BioInvent
Ascelia Pharma
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group